BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 38598033)

  • 1. Common Variable Immunodeficiency or Late-Onset Combined Immunodeficiency: A New Hypomorphic JAK3 Patient and Review of the Literature.
    Abolhassani H; Cheraghi T; Rezaei N; Aghamohammadi A; Hammarström L
    J Investig Allergol Clin Immunol; 2015; 25(3):218-20. PubMed ID: 26182690
    [No Abstract]   [Full Text] [Related]  

  • 2. Jak3 and the pathogenesis of severe combined immunodeficiency.
    O'Shea JJ; Husa M; Li D; Hofmann SR; Watford W; Roberts JL; Buckley RH; Changelian P; Candotti F
    Mol Immunol; 2004 Jul; 41(6-7):727-37. PubMed ID: 15220007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omenn Syndrome in Two Infants with Different Hypomorphic Variants in Janus Kinase 3.
    Tsilifis C; Spegarova JS; Good R; Griffin H; Engelhardt KR; Graham S; Hughes S; Arkwright PD; Hambleton S; Gennery AR
    J Clin Immunol; 2024 Apr; 44(4):98. PubMed ID: 38598033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired IL-7 signaling may explain a case of atypical JAK3-SCID.
    Li J; Nara H; Rahman M; Juliana FM; Araki A; Asao H
    Cytokine; 2010 Feb; 49(2):221-8. PubMed ID: 19889552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction.
    Candotti F; Oakes SA; Johnston JA; Notarangelo LD; O'Shea JJ; Blaese RM
    J Exp Med; 1996 Jun; 183(6):2687-92. PubMed ID: 8676091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.
    Roberts JL; Lengi A; Brown SM; Chen M; Zhou YJ; O'Shea JJ; Buckley RH
    Blood; 2004 Mar; 103(6):2009-18. PubMed ID: 14615376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined immunodeficiency evolving into predominant CD4+ lymphopenia caused by somatic chimerism in JAK3.
    Ban SA; Salzer E; Eibl MM; Linder A; Geier CB; Santos-Valente E; Garncarz W; Lion T; Ott R; Seelbach C; Boztug K; Wolf HM
    J Clin Immunol; 2014 Nov; 34(8):941-53. PubMed ID: 25205547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions.
    Dvorak CC; Haddad E; Heimall J; Dunn E; Cowan MJ; Pai SY; Kapoor N; Satter LF; Buckley RH; O'Reilly RJ; Chandra S; Bednarski JJ; Williams O; Rayes A; Moore TB; Ebens CL; Davila Saldana BJ; Petrovic A; Chellapandian D; Cuvelier GDE; Vander Lugt MT; Caywood EH; Chandrakasan S; Eissa H; Goldman FD; Shereck E; Aquino VM; Desantes KB; Madden LM; Miller HK; Yu L; Broglie L; Gillio A; Shah AJ; Knutsen AP; Andolina JP; Joshi AY; Szabolcs P; Kapadia M; Martinez CA; Parrot RE; Sullivan KE; Prockop SE; Abraham RS; Thakar MS; Leiding JW; Kohn DB; Pulsipher MA; Griffith LM; Notarangelo LD; Puck JM
    J Allergy Clin Immunol; 2023 Feb; 151(2):547-555.e5. PubMed ID: 36456360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversion Mosaicism in Primary Immunodeficiency Diseases.
    Miyazawa H; Wada T
    Front Immunol; 2021; 12():783022. PubMed ID: 34868061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity.
    Lankester AC; Albert MH; Booth C; Gennery AR; Güngör T; Hönig M; Morris EC; Moshous D; Neven B; Schulz A; Slatter M; Veys P;
    Bone Marrow Transplant; 2021 Sep; 56(9):2052-2062. PubMed ID: 34226669
    [No Abstract]   [Full Text] [Related]  

  • 11. KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection.
    Caduff N; McHugh D; Rieble L; Forconi CS; Ong'echa JM; Oluoch PO; Raykova A; Murer A; Böni M; Zuppiger L; Schulz TF; Blackbourn DJ; Chijioke O; Moormann AM; Münz C
    Cell Rep; 2021 May; 35(5):109056. PubMed ID: 33951431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical immune phenotype in severe combined immunodeficiency patients with novel mutations in IL2RG and JAK3.
    Goldberg L; Simon AJ; Lev A; Barel O; Stauber T; Kunik V; Rechavi G; Somech R
    Genes Immun; 2020 Nov; 21(5):326-334. PubMed ID: 32921793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational landscape of severe combined immunodeficiency patients from Turkey.
    Firtina S; Yin Ng Y; Hatirnaz Ng O; Kiykim A; Aydiner E; Nepesov S; Camcioglu Y; Sayar EH; Reisli I; Torun SH; Cogurlu T; Uygun D; Simsek IE; Kaya A; Cipe F; Cagdas D; Yucel E; Cekic S; Uygun V; Baris S; Ozen A; Ozbek U; Sayitoglu M
    Int J Immunogenet; 2020 Dec; 47(6):529-538. PubMed ID: 32445296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of aberrant CD8 T cell-restricted IL-7 signaling with a Janus kinase 3 defect-associated atypical severe combined immunodeficiency.
    Khanolkar A; Wilks JD; Liu G; Simpson BM; Caparelli EA; Kirschmann DA; Bergerson J; Fuleihan RL
    Immunol Res; 2020 Feb; 68(1):13-27. PubMed ID: 32215810
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.